ライフサイエンスコーパス: hematologic neoplasm

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 1) in hematopoietic cell transplantation for hematologic neoplasms.

2 , classification, staging, and monitoring of hematologic neoplasms.

3 ss in other forms of NHL as well as in other hematologic neoplasms.

4 sequencing assay and analyzed 374 samples of hematologic neoplasms.

5 resent promising targets for therapy in Ph(+)hematologic neoplasms.

6 ombocytopenia with susceptibility to diverse hematologic neoplasms.

7 ciency, increased the rate of development of hematologic neoplasms and influenced the disease spectru

8 plasm that accounts for 10% of all malignant hematologic neoplasms and that affects terminally differ

9 had systemic mastocytosis with an associated hematologic neoplasm, and 16 had mast-cell leukemia.

10 ine Pim kinases are up-regulated in specific hematologic neoplasms, and play an important role in key

11 opment, progress has been most marked in the hematologic neoplasms, both in myeloablative and in nonm

12 ymphocytosis, which are precursor states for hematologic neoplasms but are usually benign and do not

13 ll acute lymphoblastic leukemia (T-ALL) is a hematologic neoplasm characterized by malignant expansio

14 Among hematologic neoplasms, chronic myeloid leukemia (CML) is

15 mal populations have been documented in many hematologic neoplasms, including lymphoma, chronic lymph

16 Its role in other hematologic neoplasms is unclear.

17 At diagnosis or relapse of most hematologic neoplasms, malignant cells are often easily

18 arrow transplant recipient mice also develop hematologic neoplasms that appear to originate in the bo

19 dvanced systemic mastocytosis comprises rare hematologic neoplasms that are associated with a poor pr

20 apeutic target as an adjunct to treatment of hematologic neoplasms with chemo- and immunotherapy.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。